Global /South Korea /Healthcare /Drug Manufacturers - General /293480

Hana Pharm Co., Ltd.

293480

• KRX: 293480 • Delayed

9,810KRW -1.1%

6.43 USD

As of 13 June 2026, Hana Pharm Co., Ltd. has a market cap of $115.93M USD, ranking #24518 globally and #1132 in South Korea. It ranks #2191 in the Healthcare sector, and #794 in the Drug Manufacturers - General industry.

Global Rank

24518

Country Rank

1132

Sector Rank

2191

Industry Rank

794

Key Stats

Market Cap

$115.93MUSD

176.31B KRW

Revenue (TTM)

$91.62MUSD

139.33B KRW

EBITDA (TTM)

$23.15MUSD

35.33B KRW

Net Income (TTM)

$15.98MUSD

24.3B KRW

EBITDA Margin

25%

Profit Margin

17%

PE Ratio

4.4

PS Ratio

1.3

PB Ratio

2.2

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Taehong Choi open_in_new

Founded

1996

Website

hanaph.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.1%	1.7%	4.8%	-3.4%	-16%	-12%	-15%	-32%	-58%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	293480 하나제약(주) Ordinary Shares ISIN: KR7293480000 Shares Out.: Shares Outstanding: 17.723M¹ Shares Float: 6.89M² TV: TradingView: KRX: 293480 SA: Stock Analysis: KRX: 293480 YF: Yahoo Finance: 293480.KS GF: Google Finance: KRX: 293480 BA: Barron's: 293480 MS: Morningstar: XKRX: 293480	9,810 KRW	TV: TradingView: KRX: 293480 SA: Stock Analysis: KRX: 293480 YF: Yahoo Finance: 293480.KS GF: Google Finance: KRX: 293480 BA: Barron's: 293480 MS: Morningstar: XKRX: 293480

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Hana Pharm Co., Ltd.

Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1996 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 8K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 6K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 4K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 4K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 4K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 4K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 657K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 472K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 311K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 277K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 249K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 237K%	20.5	Switzerland

chevron_leftBack